Skip to main content
Erschienen in: Diabetologia 12/2013

01.12.2013 | Article

Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based study

verfasst von: M. Lind, L. A. Garcia-Rodriguez, G. L. Booth, L. Cea-Soriano, B. R. Shah, G. Ekeroth, L. L. Lipscombe

Erschienen in: Diabetologia | Ausgabe 12/2013

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

The aim of this study was to determine the contemporary rate ratio of mortality and changes over time in individuals with vs without diabetes.

Methods

Annual age- and sex-adjusted mortality rates were compared for adults (>20 years) with and without diabetes in Ontario, Canada, and the UK from January 1996 to December 2009 using The Health Improvement Network (THIN) and Ontario databases. The total number of individuals evaluated increased from 8,757,772 in 1996 to 12,696,305 in 2009.

Results

The excess risk of mortality for individuals with diabetes in both cohorts was significantly lower during later vs earlier years of the follow-up period (1996–2009). In Ontario the diabetes mortality rate ratio decreased from 1.90 (95% CI 1.86, 1.94) in 1996 to 1.51 (1.48, 1.54) in 2009, and in THIN from 2.14 (1.97, 2.32) to 1.65 (1.57, 1.72), respectively. In Ontario and THIN, the mortality rate ratios among diabetic patients in 2009 were 1.67 (1.61, 1.72) and 1.81 (1.68, 1.94) for those aged 65–74 years and 1.11 (1.10, 1.13) and 1.19 (1.14, 1.24) for those aged over 74 years, respectively. Corresponding rate ratios in Ontario and THIN were 2.45 (2.36, 2.54) and 2.64 (2.39, 2.89) for individuals aged 45–64 years, and 4.89 (4.35, 5.45) and 5.18 (3.73, 6.69) for those aged 20–44 years.

Conclusions/interpretation

The excess risk of mortality in individuals with vs without diabetes has decreased over time in both Canada and the UK. This may be in part due to earlier detection and higher prevalence of early diabetes, as well as to improvements in diabetes care.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Whiting DR, Guariguata L, Weil C, Shaw J (2011) IDF Diabetes Atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94:311–321PubMedCrossRef Whiting DR, Guariguata L, Weil C, Shaw J (2011) IDF Diabetes Atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94:311–321PubMedCrossRef
2.
Zurück zum Zitat American Diabetes Association (2011) Standards of medical care in diabetes—2011. Diabetes Care 34(Suppl. 1):S11–S61CrossRef American Diabetes Association (2011) Standards of medical care in diabetes—2011. Diabetes Care 34(Suppl. 1):S11–S61CrossRef
3.
Zurück zum Zitat Booth GL, Kapral MK, Fung K, Tu JV (2006) Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet 368:29–36PubMedCrossRef Booth GL, Kapral MK, Fung K, Tu JV (2006) Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet 368:29–36PubMedCrossRef
4.
Zurück zum Zitat Booth GL, Kapral MK, Fung K, Tu JV (2006) Recent trends in cardiovascular complications among men and women with and without diabetes. Diabetes Care 29:32–37PubMedCrossRef Booth GL, Kapral MK, Fung K, Tu JV (2006) Recent trends in cardiovascular complications among men and women with and without diabetes. Diabetes Care 29:32–37PubMedCrossRef
5.
Zurück zum Zitat Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:1577–1589PubMedCrossRef Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:1577–1589PubMedCrossRef
6.
Zurück zum Zitat Seshasai SR, Kaptoge S, Thompson A et al (2011) Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364:829–841PubMedCrossRef Seshasai SR, Kaptoge S, Thompson A et al (2011) Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364:829–841PubMedCrossRef
7.
Zurück zum Zitat Eberly LE, Cohen JD, Prineas R, Yang L, Intervention Trial Research Group (2003) Impact of incident diabetes and in incident nonfatal cardiovascular disease on 18-year mortality: the multiple risk factor intervention trial experience. Diabetes Care 26:848–854PubMedCrossRef Eberly LE, Cohen JD, Prineas R, Yang L, Intervention Trial Research Group (2003) Impact of incident diabetes and in incident nonfatal cardiovascular disease on 18-year mortality: the multiple risk factor intervention trial experience. Diabetes Care 26:848–854PubMedCrossRef
8.
Zurück zum Zitat Mulnier HE, Seaman HE, Raleigh VS, Soedamah-Muthu SS, Colhoun HM, Lawrenson RA (2006) Mortality in people with type 2 diabetes in the UK. Diabet Med 23:516–521PubMedCrossRef Mulnier HE, Seaman HE, Raleigh VS, Soedamah-Muthu SS, Colhoun HM, Lawrenson RA (2006) Mortality in people with type 2 diabetes in the UK. Diabet Med 23:516–521PubMedCrossRef
9.
Zurück zum Zitat Gregg EW, Gu Q, Cheng YJ, Narayan KM, Cowie CC (2007) Mortality trends in men and women with diabetes, 1971 to 2000. Ann Intern Med 147:149–155PubMedCrossRef Gregg EW, Gu Q, Cheng YJ, Narayan KM, Cowie CC (2007) Mortality trends in men and women with diabetes, 1971 to 2000. Ann Intern Med 147:149–155PubMedCrossRef
10.
Zurück zum Zitat Lipscombe LL, Hux JE (2007) Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995–2005: a population-based study. Lancet 369:750–756PubMedCrossRef Lipscombe LL, Hux JE (2007) Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995–2005: a population-based study. Lancet 369:750–756PubMedCrossRef
11.
Zurück zum Zitat Dale AC, Vatten LJ, Nilsen TI, Midthjell K, Wiseth R (2008) Secular decline in mortality from coronary heart disease in adults with diabetes mellitus: cohort study. BMJ 337:a236PubMedCrossRef Dale AC, Vatten LJ, Nilsen TI, Midthjell K, Wiseth R (2008) Secular decline in mortality from coronary heart disease in adults with diabetes mellitus: cohort study. BMJ 337:a236PubMedCrossRef
12.
Zurück zum Zitat Eliasson M, Talbäck M, Rosén M (2008) Improved survival in both men and women with diabetes between 1980 and 2004—a cohort study in Sweden. Cardiovasc Diabetol 7:32PubMedCrossRef Eliasson M, Talbäck M, Rosén M (2008) Improved survival in both men and women with diabetes between 1980 and 2004—a cohort study in Sweden. Cardiovasc Diabetol 7:32PubMedCrossRef
13.
Zurück zum Zitat Fox CS, Coady S, Sorlie PD et al (2004) Trends in cardiovascular complications of diabetes. JAMA 292:2495–2499PubMedCrossRef Fox CS, Coady S, Sorlie PD et al (2004) Trends in cardiovascular complications of diabetes. JAMA 292:2495–2499PubMedCrossRef
14.
Zurück zum Zitat Gregg EW, Cheng YJ, Saydah S et al (2012) Trends in death rates among U.S. adults with and without diabetes between 1997 and 2006: findings from the National Health Interview Survey. Diabetes Care 35:1252–1257PubMedCrossRef Gregg EW, Cheng YJ, Saydah S et al (2012) Trends in death rates among U.S. adults with and without diabetes between 1997 and 2006: findings from the National Health Interview Survey. Diabetes Care 35:1252–1257PubMedCrossRef
15.
Zurück zum Zitat Gulliford MC, Charlton J (2009) Is relative mortality of type 2 diabetes mellitus decreasing? Am J Epidemiol 169:455–461PubMedCrossRef Gulliford MC, Charlton J (2009) Is relative mortality of type 2 diabetes mellitus decreasing? Am J Epidemiol 169:455–461PubMedCrossRef
16.
Zurück zum Zitat Carstensen B, Kristensen JK, Ottosen P, Borch-Johnsen K, Steering Group of the National Diabetes Register (2008) The Danish National Diabetes Register: trends in incidence, prevalence and mortality. Diabetologia 51:2187–2196PubMedCrossRef Carstensen B, Kristensen JK, Ottosen P, Borch-Johnsen K, Steering Group of the National Diabetes Register (2008) The Danish National Diabetes Register: trends in incidence, prevalence and mortality. Diabetologia 51:2187–2196PubMedCrossRef
17.
Zurück zum Zitat Rodriguez LA, Cea-Soriano L, Martin-Merino E, Johansson S (2011) Discontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary care. BMJ 343:d4094PubMedCrossRef Rodriguez LA, Cea-Soriano L, Martin-Merino E, Johansson S (2011) Discontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary care. BMJ 343:d4094PubMedCrossRef
18.
Zurück zum Zitat Hux JE, Ivis F, Flintoft V, Bica A (2002) Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 25:512–516PubMedCrossRef Hux JE, Ivis F, Flintoft V, Bica A (2002) Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 25:512–516PubMedCrossRef
19.
Zurück zum Zitat Bourke A, Dattani H, Robinson M (2004) Feasibility study and methodology to create a quality-evaluated database of primary care data. Inform Prim Care 12:171–177PubMed Bourke A, Dattani H, Robinson M (2004) Feasibility study and methodology to create a quality-evaluated database of primary care data. Inform Prim Care 12:171–177PubMed
21.
Zurück zum Zitat González EL, Johansson S, Wallander MA, Rodríguez LA (2009) Trends in the prevalence and incidence of diabetes in the UK: 1996–2005. J Epidemiol Community Health 63:332–336PubMedCrossRef González EL, Johansson S, Wallander MA, Rodríguez LA (2009) Trends in the prevalence and incidence of diabetes in the UK: 1996–2005. J Epidemiol Community Health 63:332–336PubMedCrossRef
22.
Zurück zum Zitat Gulliford MC, Latinovic R, Charlton J (2008) Diabetes diagnosis, resource utilization, and health outcomes. Am J Manage Care 14:32–38 Gulliford MC, Latinovic R, Charlton J (2008) Diabetes diagnosis, resource utilization, and health outcomes. Am J Manage Care 14:32–38
23.
Zurück zum Zitat UK Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317:703–713CrossRef UK Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317:703–713CrossRef
24.
Zurück zum Zitat UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853CrossRef UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853CrossRef
25.
Zurück zum Zitat Colhoun HM, Betteridge DJ, Durrington PN, CARDS investigators et al (2004) Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 364:685–696PubMedCrossRef Colhoun HM, Betteridge DJ, Durrington PN, CARDS investigators et al (2004) Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 364:685–696PubMedCrossRef
26.
Zurück zum Zitat Harper W, Woo V, Dawson K et al (2008) Pharmacologic management of type 2 diabetes: Canadian Diabetes Association 2008 Clinical Practice Guidelines. Can J Diabetes 32(Suppl. 1):S53–S61 Harper W, Woo V, Dawson K et al (2008) Pharmacologic management of type 2 diabetes: Canadian Diabetes Association 2008 Clinical Practice Guidelines. Can J Diabetes 32(Suppl. 1):S53–S61
27.
Zurück zum Zitat Grant RW, Pirraglia PA, Meigs JB, Singer DE (2004) Trends in complexity of diabetes care in the United States from 1991 to 2000. Arch Intern Med 164:1134–1139PubMedCrossRef Grant RW, Pirraglia PA, Meigs JB, Singer DE (2004) Trends in complexity of diabetes care in the United States from 1991 to 2000. Arch Intern Med 164:1134–1139PubMedCrossRef
28.
Zurück zum Zitat Misra P, Upadhyay RP, Misra A, Anand K (2011) A review of the epidemiology of diabetes in rural India. Diabetes Res Clin Pract 92:303–311PubMedCrossRef Misra P, Upadhyay RP, Misra A, Anand K (2011) A review of the epidemiology of diabetes in rural India. Diabetes Res Clin Pract 92:303–311PubMedCrossRef
29.
Zurück zum Zitat Yang W, Lu J, Weng J, China National Diabetes and Metabolic Disorders Study Group et al (2010) Prevalence of diabetes among men and women in China. N Engl J Med 362:1090–1101PubMedCrossRef Yang W, Lu J, Weng J, China National Diabetes and Metabolic Disorders Study Group et al (2010) Prevalence of diabetes among men and women in China. N Engl J Med 362:1090–1101PubMedCrossRef
30.
Zurück zum Zitat Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM (2006) All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992–1999. Diabetologia 49:660–666PubMedCrossRef Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM (2006) All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992–1999. Diabetologia 49:660–666PubMedCrossRef
Metadaten
Titel
Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based study
verfasst von
M. Lind
L. A. Garcia-Rodriguez
G. L. Booth
L. Cea-Soriano
B. R. Shah
G. Ekeroth
L. L. Lipscombe
Publikationsdatum
01.12.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Diabetologia / Ausgabe 12/2013
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-013-3063-1

Weitere Artikel der Ausgabe 12/2013

Diabetologia 12/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.